Jupiter Research Capital (Asia) Ltd’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
SL
Jupiter Research Capital (Asia) Ltd's KYMR Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Kymera Therapeutics (KYMR) in Q3 2026, closing a stake of 9,901 shares — an estimated $1.14M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in KYMR in Q2 2026 and held it in 1 quarter. The position peaked at $1.14M in Q2 2026. 277 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Kymera Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 9,901 Kymera Therapeutics shares in Q3 2026, an estimated $1.14M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Kymera Therapeutics in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Kymera Therapeutics position peaked at $1.14M in Q2 2026.
- 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.